Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
Titel:
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
Auteur:
Douma, Li-Anne H Lalezari, Ferry van der Noort, Vincent de Vries, Jeltje F Monkhorst, Kim Smesseim, Illaa Baas, Paul Schilder, Bodien Vermeulen, Marrit Burgers, Jacobus A de Gooijer, Cornedine J